Vitamin D and Psychosis in Alzheimer Disease: New Insights From Pharmacogenomics Research

Affiliations

¹ Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
² Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA. Electronic address: Olivia.Okereke@mgh.harvard.edu.

Editorial

Chirag M Vyas et al. Am J Geriatr Psychiatry. 2019 Sep.

. 2019 Sep;27(9):918-919.

doi: 10.1016/j.jagp.2019.05.021. Epub 2019 Jun 4.

¹ Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
² Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA. Electronic address: Olivia.Okereke@mgh.harvard.edu.

No abstract available

Comment on

Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.
Wang L, Ying J, Fan P, Weamer EA, DeMichele-Sweet MAA, Lopez OL, Kofler JK, Sweet RA. Wang L, et al. Am J Geriatr Psychiatry. 2019 Sep;27(9):908-917. doi: 10.1016/j.jagp.2019.03.016. Epub 2019 Mar 27. Am J Geriatr Psychiatry. 2019. PMID: 31126722 Free PMC article.